Specific in vivo binding in the rat brain of [18F]RP 62203: A selective 5-HT2A receptor radioligand for positron emission tomography

Nuclear Medicine and Biology

Volumn 23, Issue 2, 1996, Pages 169-171

  Besret, Laurent ^a   Dauphin, François ^a   Huard, Cécile ^a   Lasne, Marie Claire ^a   Vivet, Richard ^a   Mickala, Patrick ^a   Barbelivien, Alexandra ^a   Baron, Jean Claude ^a  

^a GIP CYCERON   (France)

Author keywords

5 HT2A Receptor antagonist; 5 Hydroxytryptamine2A receptor antagonist; In vivo binding; PET; Pharmacokinetic; Positron emission tomography; Rat; RP 62203; Serotonergic receptors

Indexed keywords

FANANSERIN; FLUORINE 18; RITANSERIN; SEROTONIN 2 ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BRAIN; CYCLIC S-OXIDES; FLUORINE RADIOISOTOPES; ISOTOPE LABELING; MALE; NAPHTHALENES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RITANSERIN; SEROTONIN ANTAGONISTS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030003744     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(95)02008-X     Document Type: Article

References (29)

1. Blin J., Baron J. C., Dubois B., Crouzel C., Fiorelli M., Allar-Liang D., Pillon B., Fournier D., Vidailhet M. and Agid Y. (1993) Loss of brain 5-HT2 receptors in Alzheimer's disease. Brain 116, 497-510.
2. 18F]Setoperone: A new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo. Eur. J. Pharmacol. 147, 73-82.
3. 18F-labeled setoperone. J. Neurochem. 54, 1744-1754.
4. Boess F. G. and Martin I. L. (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33, 275-317.
5. 125I]Iodosulpiride. Neuroscience 20, 115-155.
6. 1-adrenergic receptors in rat brain with aging: A quantitative autoradiographic study. Synapse 4, 143-155.
7. 2 receptors in the rat brain: Autoradiographic visualization using a high-affinity selective agonist ligand. J. Neurosci. 7, 1352-1360.
8. Cross A. J., Crow T. J., Ferrier I. N., Johnson J. A., Bloom S. R. and Corsellis J. A. N. (1984) Serotonin receptor changes in dementia of the Alzheimer type. J. Neurochem. 43, 1575-1581.
9. Cross A. J., Slater P., Perry E. K. and Perry R. H. (1988) An autoradiographic analysis of serotonin receptors in human temporal cortex: changes in Alzheimer-type dementia. Neurochem. Int. 13, 89-96.
10. Crouzel C., Guillaume M., Barré L., Lemaire C. and Pike V. W. (1992) Ligands and tracers for PET studies of the 5-HT system - Current status. Nucl. Med. Biol. 19, 857-870.
11. 2 receptors. Eur. J. Pharmocol. 216, 53-57.
12. 125I]-HEAT membrane binding and in vitro autoradiography. Life Sci. 36, 45-51.
13. 3H]Eticlopride in the rat brain: Evidence for selective labelling of dompamine receptors. Eur. J. Pharmacol. 120, 217-226.
14. 2) by rapid "in situ" piperazine formation. Appl. Radiat. Isot. 45, 1085-1091.
15. Lemaire C., Cantineau R., Guillaume M., Plenevaux A. and Christiaens L. (1991) Fluorine-18-altanserin: A radioligand for the study of serotonin receptors with PET: Radioligand and in vivo biologic behavior in rats. J. Nucl. Med. 32, 2266-2272.
16. Leysen J. E. (1989) Use of 5-HT receptor agonists and antagonists for the characterization of their respective receptor sites. In Drugs as Took in Neurotransmitter Research (Edited by Boulton A. B., Baker G. B. and Jurio A. V.), pp. 299-349. The Humana Press Inc., Clifton, NJ.
17. Leysen J. E., Gommeren W., Van Gompel P., Wynants J., Janssen P. F. M. and Laduron P. M. (1985) Receptor-binding properties in vitro and in vivo of ritanserin. A very potent and long acting serotonin-S2 antagonist. Mol. Pharmacol. 27, 600-611.
18. 3H-ligand for serotonin receptor binding sites: Binding properties, brain distribution, and functional role. Mol. Pharmacol. 21, 301-314.
19. List S. J. and Seeman P. (1981) Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions. Proc. Natl. Acad. Sci. USA 78, 2620-2624.
20. Luabeya M. K., Maloteaux J. M. and Laduron P. M. (1984) Regional and cortical laminar distributions of serotonin S2, benzodiazepine, muscarinic, and dopamine D2 receptors in human brain. J. Neurochem. 43, 1068-1071.
21. 3H]RP 62203 binding in the rat brain. Eur. J. Pharmacol. 233, 37-45.
22. 18F-setoperone, a potential ligand for in vivo imaging of cortical serotonin receptors. Nucl. Med. Biol. 15, 463-468.
23. Middlemiss D. N., Hibert N. and Fozard J. R. (1986) Drug acting at central 5-hydroxytryptamine receptors. In Annual Report in Medicinal Chemistry (Edited by Bailey D. M.), pp. 41-50. Academic Press, San Diego.
24. Owen F., Chauters D. R., Cooper J. J., Crow T. J., Johnson J. A., Lofthouse R. and Poulter M. (1986) Serotonergic mechanisms in brains of suicide victims. Brain Res. 362, 185-188.
25. Pazos A., Cortès R. and Palacios J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346, 231-249.
26. Pazos A., Probst A. and Palacios J. M. (1987) Serotonin receptors in the human brain - IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21, 123-139.
27. Perry E. K., Perry R. H., Candy J. M., Fairbairn A. F., Blessed G., Dick D. J. and Tomlinson B. E. (1984) Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: Comparisons with Parkinson's disease. Neurosci. Lett. 51, 353-357.
28. 2 receptors and their involvement in schizoprenic and neuroleptic drug action. J. Neural. Transm. (Suppl.) 18, 273-277.
29. Zifa E. and Fillion G. (1992) 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44, 401-458.